Page 259 - Drug Class Review
P. 259

Drug Effectiveness Review Project














                          Alzheimer Drugs   Authors: Cutler et al. 81    Year: 1998   NR   Study design: Pooled data analysis   Number of patients: 3,350  To determine the incidence rates of adverse events for TAC, DON, and RIV      NR   NR   RCTs   NR   Page 160 of 205

























             Final Report Update 1     Adverse Events      STUDY:      FUNDING:      DESIGN:          AIMS OF REVIEW:   STUDIES INCLUDED IN   REVIEW     TIME PERIOD COVERED:     CHARACTERISTICS OF  INCLUDED STUDIES:     CHARACTERISTICS OF  INCLUDED POPULATIONS:           Alzheimer's Drugs
   254   255   256   257   258   259   260   261   262   263   264